SRTS (Sensus Healthcare) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 24, 2026)


SRTS Sensus Healthcare Inc SRTS
76 GF Score
Price $2.92
GF Value $2.85
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Sensus Healthcare Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Sensus Healthcare's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

SRTS vs ELUT, COCH, BDMD: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Devices subindustry, Sensus Healthcare's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sensus Healthcare Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sensus Healthcare's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Sensus Healthcare's Margin of Safety % (DCF Earnings Based) falls into.


SRTS
76GF Score
Sensus Healthcare Inc SRTS
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sensus Healthcare (SRTS) Overvalued in 2026?

Based on GuruFocus' analysis, Sensus Healthcare stock appears to be overvalued. The current stock price of $2.92 is trading 2.5% above its estimated GF Value™ of $2.85. GuruFocus considers Sensus Healthcare to be Fairly Valued.

Key valuation signals for SRTS:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $2.85 vs. price of $2.92 (2.5% above fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the SRTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sensus Healthcare Business Description

Other Exchanges 5TX:Germany
Address 851 Broken Sound Parkway, NW, Suite 215, Boca Raton, FL, USA, 33487
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
76GF Score

Get the complete analysis for SRTS

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.92
Price
$2.85
GF Value